一级婬片试看120分钟,安徽少妇BBBB搡BBBB,波多野结衣一级片

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<tr id="cc0cc"></tr>

<nav id="cc0cc"></nav><small id="cc0cc"></small>

<sup id="cc0cc"></sup>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

视色4se免费无码网站 | 少产高潮一区二区三区久久 | 中文字幕免费视频在线观看 | 国色不卡尤物dvd视频 | 18无码粉嫩小泬无套 | 国产码高潮尤在线观看 | 国产精品嫩草影院久久久 | 精品人妻二区三区蜜桃 | 91丨国产丨白浆秘洗澡动漫 | 高清在线观看网站无码 | 色情免费无码日韩电话 | 国产又粗又猛又黄又爽无遮挡 | 免费无码婬片A片AAA毛多多 | 婬乱的妇女HD中文字幕 | 亚洲美色精品婷婷 | JUKD575中文字幕人妻 | 国产一区二区三区三区在线视频观看 | 日本在线一区二区三区 | 黑人玩弄人妻一区二区三区视频 | 精品A片老女人免费看一区国产麻豆一级黄色视频资源 | 免费无码A片在线观看全 | 两个人爽爽视频免费观看 | 国产一级婬片A片AAA樱花 | 国产成人精品AA毛片 | 无码午夜精品一区二区三区视频 | 国产精品扒开腿做爽爽爽A片唱戏 | 大乳奶一级婬片A片无码小说姜怡 | 成人国产精品秘鲁鲁3D | 少妇人妻偷人精品视频蜜桃 | 女女蕾丝边一区二区三区国产 | 红桃视频网站一区二区精品 | 国产精品熟女一区二区不卡 | 最骚少妇A片免费短视频 | 国产精品三级片久色 | 香港三日本三级少妇66 | 最近最新MV字幕免费观看 | 国产探花在线精品一区二区 | 老熟女老女人老熟妇av | 免费做受高潮 | 稚嫩A∨一区二区三区 | 国产熟女真实乱精品视频 |

<tfoot id="ccccc"><dd id="ccccc"></dd></tfoot>

<nav id="ccccc"></nav>

<tr id="ccccc"></tr><tr id="ccccc"></tr>

<noscript id="ccccc"><dd id="ccccc"></dd></noscript>